News

Under the agreement, ARCA will receive an upfront payment of $2m and is eligible to receive clinical, regulatory and commercial amount totaling $17.5m. ARCA is also currently seeking

According to preclinical studies across multiple animal models, the NAV technology, and in particular NAV rAAV8 vector, targets the photoreceptor layer to preserve vision using gene delivery approaches.

Debio 1036 is an orally available small molecule that antagonizes a key mediator in the inflammation process. The tie up aims at developing inhibitors targeting a fundamental inflammatory

Rhinolast Allergy is a non-steroid treatment and is suitable for children from as young as five years old. Meda Pharma claims Rhinolast Allergy targets the symptoms of red,

The company has reported net earnings of $104.55m, compared to $94.27m for the same period prior year. For the first quarter of 2011, Mylan‘s earnings from operations was

Pro-Pharma’s lead product candidate Davanat is a carbohydrate polymer that targets Galectin proteins that are over-expressed by cancer cells and interferes with their activity. According to studies, Galectins

As per the agreement, ALDA Pharma’s personnel will undertake the marketing and sales of Seavan’s products and services in addition to those of ALDA. ALDA Pharma president and

With this acquisition, Hikma Pharma expects to enhance its Injectables platform across the world. Following the acquisition, Hikma will divest two West-Ward products, Phenytoin and Promethazine, as required

Net income attributable to the company was $2.22bn for the first quarter of 2011, compared to $2.02bn for the same period last year. For full-year 2011, Pfizer anticipated